To determine if SAL is involved in the regulation of liver fibrosis through the PI3K/AKT/GSK-3β signaling pathway, LY294002, a PI3K inhibitor, was applied to HSC and effectively reversed the inhibitory effect of SAL on GSK-3β. Here, GSK3B is linked to Hepatic fibrosis.